Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion type Assertion NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_head.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion description "[Aberrant methylation of TFPI-2 was also detected in 73% (102/140) of pancreatic cancer xenografts and primary pancreatic adenocarcinomas, was more likely in older patients with pancreatic cancer, and significantly correlated with progression of IPMNs (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_provenance.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion evidence source_evidence_literature NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_provenance.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion SIO_000772 15592528 NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_provenance.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion wasDerivedFrom befree-20150227 NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_provenance.
- NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_assertion wasGeneratedBy ECO_0000203 NP787396.RAml-RCEBJNYZNA-hpqvZnW52Kfsvr-M7owDFXKYpJexI130_provenance.